GLP 1 receptor agonists
Rosen CJ, Ingelfinger JR
N Engl J Med. Pub. online 1 Apr 2026.
Leggi
Toward personalized medicine in type 1 diabetes: understanding how patient heterogeneity influences therapeutic efficacy
Pipella J, Thompson PJ
Diabetes Obes Metab. Pub. online 30 Mar 2026.
Leggi
Efficacy and safety of GLP-1 receptor agonists for adolescents and children with obesity: a meta-analysis of randomized controlled trials
Chen Q, Liu H, Xu J, et al.
BMC Endocr Disord. Pub. online 31 Mar 2026.
Leggi
Accuracy of continuous glucose monitoring in adults with postbariatric hypoglycemia after roux-en-y gastric bypass surgery under stable and dynamic glucose conditions
Lizoain A, Vettoretti M, Ferreira A, et al.
Diabetes Care. Pub. online 31 Mar 2026.
Leggi
Estimating the true MACE benefits from tirzepatide in SURPASS-CVOT using an imputed placebo analysis of REWIND
Sattar N, Gerstein HC, D’Alessio D, et al.
Diabetes Care. Pub. online 6 Apr 2026.
Leggi
Artificial intelligence in diabetes care
Dubský M, Liegertová M, Bém R, et al.
Diabetes Obes Metab. Pub. online 30 Mar 2026.
Leggi
NUOVA INIZIATIVA PODCAST DIGITAL HEALTH
Carissimi Soci, prendono avvio i nuovi podcast sulla Digital Health AMD, uno spazio di esplorazione e ascolto, per uscire dai confini abituali della professione e per “allenare” uno sguardo più ampio. Un’iniziativa che nasce per accompagnare la comunità diabetologica in una fase di profonda trasformazione in cui sta cambiando il…
Leggi
2026 dietary guidance to improve cardiovascular health: a scientific statement from the American Heart Association
Lichtenstein AH, Khera A, Anderson CAM, et al.
Circulation. Pub. online 31 Mar 2026.
Leggi
Safety of GLP‐1 and dual GLP‐1/GIP receptor agonists in preconception, pregnancy, and lactation: a systematic review of maternal, fetal, and neonatal outcomes
Ozbek L, Shah E, Al-Shiab R, et al.
Diabetes Obes Metab. Pub. online 26 Mar 2026.
Leggi